Peptide Graded

Nangibotide

Is Nangibotide safe?

One infusion course studied only

BSome human evidenceIn clinical trialsas of 2026-10-26

In ASTONISH, adverse events were similar with nangibotide and placebo. This matters because septic shock patients are already very sick, and extra harm would have been easy to miss. Death was not the main outcome. The trial was not powered to detect a difference in deaths. No one has studied safety beyond a single infusion course, or in people who are not in septic shock. 1

Read the full Nangibotide page

More on Nangibotide

Citations

  1. François 2023, Lancet Respir Med: nangibotide in patients with septic shock (ASTONISH), randomized phase 2b trial doi.org

Reference information only, not medical advice. Drawn from the Nangibotide article, fact-checked against the cited sources. No dosing anywhere on this site.